These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Trends in the Source of Prescription Drugs for Misuse between 2015 and 2019. Purser GL Subst Use Misuse; 2023; 58(7):871-880. PubMed ID: 36987981 [No Abstract] [Full Text] [Related]
4. Nonmedical use of prescription opioids and stimulants among student pharmacists. Lord S; Downs G; Furtaw P; Chaudhuri A; Silverstein A; Gammaitoni A; Budman S J Am Pharm Assoc (2003); 2009; 49(4):519-28. PubMed ID: 19589764 [TBL] [Abstract][Full Text] [Related]
5. Policies to mitigate nonmedical use of prescription medications: how should emerging evidence of gabapentin misuse be addressed? Peckham AM; Fairman KA; Sclar DA Expert Opin Drug Saf; 2018 May; 17(5):519-523. PubMed ID: 28985090 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and correlates of the misuse of z-drugs and benzodiazepines in the National Survey on Drug Use and Health. McHugh RK; Votaw VR; Trapani EW; McCarthy MD Front Psychiatry; 2023; 14():1129447. PubMed ID: 36970272 [TBL] [Abstract][Full Text] [Related]
7. Attributes, Attitudes, and Practices of Clinicians Concerned with Opioid Prescribing. Razouki Z; Khokhar BA; Philpot LM; Ebbert JO Pain Med; 2019 Oct; 20(10):1934-1941. PubMed ID: 30403814 [TBL] [Abstract][Full Text] [Related]
8. Transitions in Prescription Benzodiazepine Use and Misuse and in Substance Use Disorder Symptoms Through Age 50. McCabe SE; Schulenberg JE; Wilens TE; Schepis TS; McCabe VV; Veliz P Psychiatr Serv; 2023 Nov; 74(11):1154-1162. PubMed ID: 37143335 [TBL] [Abstract][Full Text] [Related]
9. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines. Manders L; Abd-Elsayed A Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396 [TBL] [Abstract][Full Text] [Related]
11. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect. Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965 [TBL] [Abstract][Full Text] [Related]
12. The US Opioid Crisis: Current Federal and State Legal Issues. Soelberg CD; Brown RE; Du Vivier D; Meyer JE; Ramachandran BK Anesth Analg; 2017 Nov; 125(5):1675-1681. PubMed ID: 29049113 [TBL] [Abstract][Full Text] [Related]
14. Effect of Controlled Substance Use Management on Prescribing Patterns and Health Outcomes Among High-Risk Users. Chen X; Ma Q; Barron J; DeVries A; Horn J; Agiro A J Manag Care Spec Pharm; 2019 Mar; 25(3):392-401. PubMed ID: 30816820 [TBL] [Abstract][Full Text] [Related]
15. Misuse of Prescription and Illicit Drugs in Middle Adulthood in the Context of the Opioid Epidemic. Faller RW; Erausquin JT; McCoy TP Subst Use Misuse; 2021; 56(2):333-337. PubMed ID: 33325317 [No Abstract] [Full Text] [Related]
16. Medical use and misuse of psychoactive prescription medications among US youth and young adults. Agaku I; Odani S; Nelson J Fam Med Community Health; 2021 Jan; 9(1):. PubMed ID: 33536180 [TBL] [Abstract][Full Text] [Related]
17. An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: is Europe next? Helmerhorst GT; Teunis T; Janssen SJ; Ring D Bone Joint J; 2017 Jul; 99-B(7):856-864. PubMed ID: 28663389 [TBL] [Abstract][Full Text] [Related]
18. Impact of CancelRx on discontinuation of controlled substance prescriptions: an interrupted time series analysis. Watterson TL; Stone JA; Gilson A; Brown R; Xiong KZ; Schiefelbein A; Ramly E; Kleinschmidt P; Semanik M; Craddock L; Pitts SI; Woodroof T; Chui MA BMC Med Inform Decis Mak; 2022 Feb; 22(1):50. PubMed ID: 35216591 [TBL] [Abstract][Full Text] [Related]